Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells
and either kill them or deliver tumor-killing substances to them without harming normal
cells. Combining chemotherapy, monoclonal antibody therapy, and surgery may be a more
effective treatment for breast cancer.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, monoclonal
antibody therapy, and surgery in treating women who have stage II, stage III, or stage IV
breast cancer.